Ameriprise’s Medallia, Inc. MDLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-70,135
Closed -$2.38M 4111
2021
Q3
$2.38M Sell
70,135
-204,455
-74% -$6.83M ﹤0.01% 2807
2021
Q2
$9.27M Sell
274,590
-1,444,291
-84% -$41.5M ﹤0.01% 1999
2021
Q1
$47.9M Buy
1,718,881
+666,054
+63% +$24.7M 0.02% 785
2020
Q4
$35M Sell
1,052,827
-125,622
-11% -$4.01M 0.01% 906
2020
Q3
$32.3M Buy
1,178,449
+27,465
+2% +$833K 0.01% 825
2020
Q2
$29.1M Buy
1,150,984
+715,451
+164% +$17.1M 0.01% 863
2020
Q1
$8.73M Buy
435,533
+372,079
+586% +$10M ﹤0.01% 1491
2019
Q4
$1.97M Buy
63,454
+25,983
+69% +$768K ﹤0.01% 2733
2019
Q3
$1.03M Buy
+37,471
New +$1.33M ﹤0.01% 3008

Ameriprise's MDLA Position: Q4 2021 in Review

Ameriprise sold out of Medallia, Inc. (MDLA) in Q4 2021, closing a stake of 70,135 shares — an estimated $2.38M sold.

Ameriprise first reported a position in MDLA in Q3 2019 and held it in 9 quarters. The position peaked at $47.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold MDLA as of Q4 2021.

  • Ameriprise reported no remaining Medallia, Inc. position as of Q4 2021 after selling out during the quarter.
  • Ameriprise sold 70,135 Medallia, Inc. shares in Q4 2021, an estimated $2.38M.
  • Ameriprise first reported a position in Medallia, Inc. in Q3 2019 and held it in 9 quarters.
  • Ameriprise's Medallia, Inc. position peaked at $47.9M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Medallia, Inc. as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.